Source:Hong Kong Economic JournalChen Qiyu, Executive Director and Co-CEO of Fosun International has conducted an interview with Hong Kong Economic Journal right after the 2023 Interim Results Announcement. The article has been published on 14 September with title of “Focus on Core Businesses and Seize the Opportunity of Economic Recovery, Globalization + Innovation to

Fosun International 2023 interim results show steady growth amid global headwindspublished on The Asset.com 13 Sep 2023Fosun International Limited has maintained steady overall business growth despite the slow economic recovery.Focusing on its core businesses, the Chinese multinational group reported revenue of 97.06 billion yuan (US$13.28 billion) for the six months to June 2023, a 10

lHANSIZHUANG’s coverage footprint includes 22 emerging market countries across Southeast Asia and MENA.lKGbio to develop and commercialise HANSIZHUANG in 12 MENA countries; Henlius to receive US$7 million upfront payment plus royalties and up to US$8 million in regulatory milestone payments.lHenlius is eligible to receive up to US$650 million upon the achievement of sales

Fosun International Announces 2023 Interim Results: Leveraging Innovation to March Towards High-quality DevelopmentIn the first half of 2023, as the economy and society fully returned to normalcy, macroeconomic policies started to take effect, and the national economy witnessed recovery and growth, China’s gross domestic product (GDP) reached RMB59

"It is very clear that we have won out over the cycle and Fosun's liquidity pressure has been well managed. We will focus on the development of businesses where we boast clear competitive advantages. Development is the key solution to all issues."On 31 August, Fosun International held the 2023 interim results presentation, during which Guo Guangchang, Ch

The sixth themed month of WE Volunteer——August’s“Care for Community Month”comes to a close! The community is not only the fundamental unit of life but also a bond that connects emotions. Through community care, we can create a warmer and more vibrant community environment, enhancing residents' sense of cohesion and belonging. Over the past month, we

Group’s Resilient Business Model Sees Growth Across All Channels and Geographies·Group Revenue of €215 million for H1 2023, a 6.4% increase over H1 2022·Group Gross Profit Margin improved to 58.5% and Contribution Profit Margin(1)up significantly to 6.9%; on track to achieve Adjusted EBITDA breakeven in FY2024·Group Revenue increased in all channels and geographie

2023 Interim Results Highlights:Steady growth of business, total revenue was RMB97.06 billion, representing a year-on-year increase of 10.9%Significant improvement in core businesses, industrial operation profit was RMB3.37 billion, representing a year-on-year increase of 66%Driving development with technologyInnovation, R&D investment reached RMB4.2 billionRobust mom

(August 29 2023, Shanghai, China) On August 29, 2023, Shanghai Fosun Pharmaceutical Co., Ltd.* (Stock Code: 600196.SH; 02196.HK)announced its 2023 Interim Results for the first half of 2023. (the “Reporting Period”). During the Reporting Period, Fosun Pharma achieved revenue of RMB21.395 billion; the net profit attributable to shareholders of the listed company was